Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John M Davis

Showing results (71-80 of 505) with videos related to

Pageof 51
Sort By:
Neuropharmacology|June 21, 2005
Imidazenil: an antagonist of the sedative but not the anticonvulsant action of diazepamJames Auta, Erminio Costa, John M Davis, et al.
The Journal of Clinical Psychiatry|December 9, 2003
Olanzapine for self-injurious, aggressive, and disruptive behaviors in intellectually disabled adults: a retrospective, open-label, naturalistic trialDavid S Janowsky, L Jarrett Barnhill, John M Davis
Pharmacology, Biochemistry, and Behavior|January 31, 2004
Antagonism of anticholinesterase (DFP) toxicity by donepezil plus scopolamine: a preliminary studyDavid S Janowsky, John M Davis, David H Overstreet
The American Journal of Psychiatry|December 8, 2006
Switch or stay?John M Davis, Stephen R Marder, Carol A Tamminga
Evolutionary Applications|March 26, 2021
Why women have more autoimmune diseases than men: An evolutionary perspectiveVanessa L Kronzer, Stanley Louis Bridges, John M Davis
Rheumatology International|July 25, 2019
The impact of gender on time to rheumatoid arthritis classification: a retrospective analysis of a population-based cohortCaitrin M Coffey, John M Davis, Cynthia S Crowson
The Journal of Clinical Psychiatry|April 12, 2008
Treating schizophrenia with comorbid depressive or demoralization symptomsIra D Glick, Samuel G Siris, John M Davis
Current Psychiatry Reports|November 21, 2002
Historical studies of premenstrual tension up to 30 years ago: implications for future researchDavid S Janowsky, Jeffrey L Rausch, John M Davis
Rheumatic Diseases Clinics of North America|November 4, 2022
Epidemiologic Opportunities and Challenges in Studying Environmental Risk Factors for Rheumatic DiseasesVanessa L Kronzer, John M Davis, Cynthia S Crowson
The American Surgeon|July 21, 2020
Sporogenic Aspergillus Infections: A Geographical Influence in an Invariable Trauma PopulationTaylor Turnbull, Ryan Taylor, Jason D Sciarretta, et al.
Pageof 51

Showing results (71-80 of 505) with videos related to

Sort By:
Pageof 51
Neuropharmacology|June 21, 2005
Imidazenil: an antagonist of the sedative but not the anticonvulsant action of diazepamJames Auta, Erminio Costa, John M Davis, et al.
The Journal of Clinical Psychiatry|December 9, 2003
Olanzapine for self-injurious, aggressive, and disruptive behaviors in intellectually disabled adults: a retrospective, open-label, naturalistic trialDavid S Janowsky, L Jarrett Barnhill, John M Davis
Pharmacology, Biochemistry, and Behavior|January 31, 2004
Antagonism of anticholinesterase (DFP) toxicity by donepezil plus scopolamine: a preliminary studyDavid S Janowsky, John M Davis, David H Overstreet
The American Journal of Psychiatry|December 8, 2006
Switch or stay?John M Davis, Stephen R Marder, Carol A Tamminga
Evolutionary Applications|March 26, 2021
Why women have more autoimmune diseases than men: An evolutionary perspectiveVanessa L Kronzer, Stanley Louis Bridges, John M Davis
Rheumatology International|July 25, 2019
The impact of gender on time to rheumatoid arthritis classification: a retrospective analysis of a population-based cohortCaitrin M Coffey, John M Davis, Cynthia S Crowson
The Journal of Clinical Psychiatry|April 12, 2008
Treating schizophrenia with comorbid depressive or demoralization symptomsIra D Glick, Samuel G Siris, John M Davis
Current Psychiatry Reports|November 21, 2002
Historical studies of premenstrual tension up to 30 years ago: implications for future researchDavid S Janowsky, Jeffrey L Rausch, John M Davis
Rheumatic Diseases Clinics of North America|November 4, 2022
Epidemiologic Opportunities and Challenges in Studying Environmental Risk Factors for Rheumatic DiseasesVanessa L Kronzer, John M Davis, Cynthia S Crowson
The American Surgeon|July 21, 2020
Sporogenic Aspergillus Infections: A Geographical Influence in an Invariable Trauma PopulationTaylor Turnbull, Ryan Taylor, Jason D Sciarretta, et al.
Pageof 51